Asgard Therapeutics’ Financing Round

Roschier represented RV Invest and Johnson & Johnson Innovation on the deal. Asgard Therapeutics AB, a Swedish biotech company pioneering in vivo direct cell reprogramming for...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Avalara’s Public Offer for Pagero

Roschier represented Avalara on the transaction. Avalara, Inc. executed a public offer to the shareholders of Pagero Group AB (publ). The total value of the offer is...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here